Analysis of Repeat Step-up Dosing and Cytokine Release Syndrome Events Following Prolonged Dosing Intervals of Teclistamab in the Phase 1/2 Majestec-1 Study
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Niels W.C.J. van de Donk, Ajai Chari, Lionel Karlin, Amrita Y Krishnan, Katarina Uttervall, Thomas Chalopin, Laura Rosinol Dachs, Albert Oriol, Jeffrey V Matous, Manisha Bhutani, Cesar Rodriguez, Natalia A Quijano Cardé, Yue Guo, Caroline Hodin, Clarissa Uhlar, Tara Stephenson, Athena Zuppa, Margaret Doyle, Katherine Chastain, Alfred L Garfall
Institutions: Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, University of California, San Francisco, Hôpital Lyon Sud, City Of Hope National Medical Center, City of Hope, Karolinska University Hospital, Centre Hospitalier Universitaire de Tours, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Colorado Blood Cancer Institute, Levine Cancer Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Janssen (Belgium), Janssen Research & Development (United States), Janssen (Ireland), University of Pennsylvania
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405039266